Safety profile of baricitinib for the treatment of rheumatoid arthritis up to 9.3 years: an updated integrated safety analysis

Detalhes bibliográficos
Principais autores:	Taylor, P, Takeuchi, T, Burmester, G, Durez, P, Smolen, J, Deberdt, W, Zhong, J, Teres, JR, Bello, N, Winthrop, K, Pope, J
Formato:	Conference item
Idioma:	English
Publicado em:	Journal of Rheumatology 2022

Registros relacionados